Shopping Cart 0
Cart Subtotal
USD 0

Dura Substitutes (Neurology) - Global Market Analysis and Forecast Model

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 7500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 15000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 22500

Details

Dura Substitutes (Neurology)-Global Market Analysis and Forecast Model
 
Summary
 
Dura Substitutes (Neurology)-Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Neurology Devices therapeutic area.
 
Dura substitutes are patches which are used as sheet or material in repairing the dura mater in craniotomy or spinal fusion procedures. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. The model considers two types of dura substitutes, biological and synthetic. Biological substitutes are made by bio engineering of tissues from different animals like cow (bovine pericardium) and pig (porcine intestinal sub mucosal layer). These materials are high in collagen fibers and known for their low tendency to cause immunological reactions. Synthetic substitutes are made from polymer materials such as Polytetrafluoroethylene (PTFE) and have high tensile strength.
 
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
 
Key Inclusions of the market Model
 
Currently marketed dura substitutes and evolving competitive landscape-
- Insightful review of the key industry trends.
- Annualized total dura substitutes market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.
 
Global, Regional and Country level market specific insights-
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for dura substitutes market.
- Competitive dynamics insights and trends provided for dura substitutes market.
 
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
 
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
 
Companies covered: B. Braun Melsungen AG, Biosynth Lifesciences, DePuy Synthes, Medtronic plc, Integra LifeSciences Corporation, Cook Group, Medical Biomaterial Products GmbH, Stryker Corporation, Baxter International Ltd, Tissuemed Ltd, Guanhao Biotech, W. L. Gore & Associates Inc, Cousin Biotech Sarl, GUNZE LIMITED, Medprin Regenerative Medical Technologies Co., Ltd., Acera Surgical, Inc.
 
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
 
Scope
 
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for-
- CMO executives who must have deep understanding of the dura substitutes marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
 
Reasons to buy
 
The model will enable you to-
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving dura substitutes market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the dura substitutes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific dura substitutes market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
READ MORE

Table Of Content

Scope

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Dura substitutes, biological, synthetic, spinal fusion, craniotomy


Companies

B. Braun Melsungen AG
Biosynth Lifesciences
DePuy Synthes
Medtronic plc
Integra LifeSciences Corporation
Cook Group
Medical Biomaterial Products GmbH
Stryker Corporation
Baxter International Ltd
Tissuemed Ltd
Guanhao Biotech
W. L. Gore & Associates Inc
Cousin Biotech Sarl
GUNZE LIMITED
Medprin Regenerative Medical Technologies Co. Ltd.
Acera Surgical Inc.

Company Profile

Company Profile Title

Dura Substitutes (Neurology)-Global Market Analysis and Forecast Model
 
Summary
 
Dura Substitutes (Neurology)-Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Neurology Devices therapeutic area.
 
Dura substitutes are patches which are used as sheet or material in repairing the dura mater in craniotomy or spinal fusion procedures. Closure or repair of dura mater is essential to prevent a cerebrospinal fluid (CSF) leak. The model considers two types of dura substitutes, biological and synthetic. Biological substitutes are made by bio engineering of tissues from different animals like cow (bovine pericardium) and pig (porcine intestinal sub mucosal layer). These materials are high in collagen fibers and known for their low tendency to cause immunological reactions. Synthetic substitutes are made from polymer materials such as Polytetrafluoroethylene (PTFE) and have high tensile strength.
 
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
 
Key Inclusions of the market Model
 
Currently marketed dura substitutes and evolving competitive landscape-
- Insightful review of the key industry trends.
- Annualized total dura substitutes market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.
 
Global, Regional and Country level market specific insights-
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for dura substitutes market.
- Competitive dynamics insights and trends provided for dura substitutes market.
 
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
 
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
 
Companies covered: B. Braun Melsungen AG, Biosynth Lifesciences, DePuy Synthes, Medtronic plc, Integra LifeSciences Corporation, Cook Group, Medical Biomaterial Products GmbH, Stryker Corporation, Baxter International Ltd, Tissuemed Ltd, Guanhao Biotech, W. L. Gore & Associates Inc, Cousin Biotech Sarl, GUNZE LIMITED, Medprin Regenerative Medical Technologies Co., Ltd., Acera Surgical, Inc.
 
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
 
Scope
 
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for-
- CMO executives who must have deep understanding of the dura substitutes marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
 
Reasons to buy
 
The model will enable you to-
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving dura substitutes market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the dura substitutes market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific dura substitutes market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
READ MORE

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Dura substitutes, biological, synthetic, spinal fusion, craniotomy


Companies

B. Braun Melsungen AG
Biosynth Lifesciences
DePuy Synthes
Medtronic plc
Integra LifeSciences Corporation
Cook Group
Medical Biomaterial Products GmbH
Stryker Corporation
Baxter International Ltd
Tissuemed Ltd
Guanhao Biotech
W. L. Gore & Associates Inc
Cousin Biotech Sarl
GUNZE LIMITED
Medprin Regenerative Medical Technologies Co. Ltd.
Acera Surgical Inc.